T. Rowe Price Associates
AXNX

T. Rowe Price Associates’s Axonics, Inc. Common Stock AXNX Stock Holding History

T. Rowe Price Associates’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31,286
Closed -$2.18M – 3083
2024
Q3 		$2.18M Buy
31,286
+403
+1% +$27.6K ﹤0.01% 1597
2024
Q2 		$2.08M Buy
30,883
+1,986
+7% +$134K ﹤0.01% 1536
2024
Q1 		$1.99M Buy
28,897
+1,828
+7% +$123K ﹤0.01% 1566
2023
Q4 		$1.69M Buy
27,069
+1,416
+6% +$79.2K ﹤0.01% 1625
2023
Q3 		$1.44M Buy
25,653
+1,166
+5% +$65.6K ﹤0.01% 1621
2023
Q2 		$1.24M Buy
24,487
+1,804
+8% +$96K ﹤0.01% 1693
2023
Q1 		$1.24M Buy
22,683
+756
+3% +$44.2K ﹤0.01% 1675
2022
Q4 		$1.37M Buy
21,927
+676
+3% +$44.9K ﹤0.01% 1616
2022
Q3 		$1.5M Buy
21,251
+10,385
+96% +$716K ﹤0.01% 1566
2022
Q2 		$616K Buy
10,866
+326
+3% +$17.9K ﹤0.01% 2136
2022
Q1 		$660K Sell
10,540
-19,087
-64% -$1.03M ﹤0.01% 2218
2021
Q4 		$1.66M Sell
29,627
-398,493
-93% -$24.4M ﹤0.01% 1790
2021
Q3 		$27.9M Sell
428,120
-3,233
-0.7% -$221K ﹤0.01% 1200
2021
Q2 		$27.4M Sell
431,353
-29,111
-6% -$1.72M ﹤0.01% 1224
2021
Q1 		$27.6M Sell
460,464
-2,268
-0.5% -$123K ﹤0.01% 1192
2020
Q4 		$23.1M Sell
462,732
-312
-0.1% -$14.6K ﹤0.01% 1189
2020
Q3 		$23.6M Buy
463,044
+933
+0.2% +$38.9K ﹤0.01% 1110
2020
Q2 		$16.2M Buy
+462,111
New +$15.9M ﹤0.01% 1192

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

T. Rowe Price Associates's AXNX Position: Q4 2024 in Review

T. Rowe Price Associates sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 31,286 shares — an estimated $2.18M sold.

T. Rowe Price Associates first reported a position in AXNX in Q2 2020 and held it in 18 quarters. The position peaked at $27.9M in Q3 2021. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • T. Rowe Price Associates reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 31,286 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.18M.
  • T. Rowe Price Associates first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 18 quarters.
  • T. Rowe Price Associates's Axonics, Inc. Common Stock position peaked at $27.9M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.